| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/25/2008 | US20080233120 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 09/25/2008 | US20080233052 Contrast Agents |
| 09/25/2008 | US20080233051 Organically modified silica nanoparticle incorporate two-photon absorption dye 9,10-Bis[4'-styryl-styryl]anthracenes and photosensizer 2-devinyl-2-(1-hexyloxyethyl)pyropheophorbide activated by fluorescence resonance energy transfer; displays unique aggregation induced fluorescence enhancement behavior |
| 09/25/2008 | US20080233050 Using cyanine dyes; in situ supplying to tumor cells |
| 09/25/2008 | US20080233049 Neurotrophin-3, P75 receptor ligand polypeptide activating neuronal endocytosis, axonal transport, and synaptic transfer; imaging agent determine location, evaluate neuronal transport in patient; fluorescent microscopy or single photon emission computerized tomography |
| 09/25/2008 | US20080233048 Powder by mixing and pulverizing an isotope-labeled uracil, or metabolite labeled with an isotope of carbon atoms, oxygen atoms, or nitrogen atoms and mannitol; time required for the determination and number of measurements can be reduced, decreasing the burden on patients |
| 09/25/2008 | DE102007013415A1 Verbundwerkstoff Composite material |
| 09/25/2008 | CA2680762A1 Pet visualization of amyloid-associated neuroinflammation in the brain |
| 09/24/2008 | EP1972935A1 Screening method for infectious agent of prion disease |
| 09/24/2008 | EP1971355A2 Methods and compositions for delivering active agents with enhanced pharmacological properties |
| 09/24/2008 | CN101272808A Optical imaging |
| 09/24/2008 | CN101272800A Cupredoxin derived transport agents and methods of use thereof |
| 09/24/2008 | CN101270124A Novel method for purifying and preparing high-purity fluorandiol and fluorandiol salt |
| 09/23/2008 | US7427496 To inhibit tumor growth in an animal; to induce apoptosis |
| 09/23/2008 | US7427393 Pharmaceutical preparation containing magnetic vesicular particles, manufacturing method thereof and diagnostic therapeutic system |
| 09/23/2008 | US7427392 Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau |
| 09/23/2008 | US7427391 Formulations for use in medical and diagnostic procedures |
| 09/23/2008 | CA2303426C Contrast-enhanced diagnostic imaging method for monitoring interventional therapies |
| 09/23/2008 | CA2262685C Process and device for separating magnetic materials from pharmaceutical compositions, their starting or intermediate products and agents produced by means of this device |
| 09/18/2008 | WO2008111687A1 Imaging agent for detection of sentinel lymph node comprising thermoresponsive magnetic nanoparticle |
| 09/18/2008 | WO2008110958A1 Method of controlling a release of a material carried by ultrasound sensitive particles |
| 09/18/2008 | WO2008109997A1 Procaspase 8-mediated disease targeting |
| 09/18/2008 | WO2008097485A3 Probes for ultrasound imaging systems |
| 09/18/2008 | WO2008089135A3 Identification of biomarkers predictive of dasatinib effects in cancer cells |
| 09/18/2008 | WO2008088524A3 Thrombospondin-domain-deficient r-spondin 1 protein as gastrointestinal tract epithelial proliferation factor |
| 09/18/2008 | WO2007120830A3 Methods of modeling migraine pain and identifying candidate compounds for the treatment of migraine |
| 09/18/2008 | US20080228049 Systems, Circuits and Apparatus For In Vivo Detection of Biomolecule Concentrations Using Fluorescent Tags |
| 09/18/2008 | US20080226646 Use of biomolecular targets in the treatment and visualization of tumors |
| 09/18/2008 | US20080226631 Methods of modulating cytokine activity; related reagents |
| 09/18/2008 | US20080226564 Bioactive material in perforated microstructure; propellant suspension; mixture of bronchodilator and antiinflammatory agent |
| 09/18/2008 | US20080226563 Non-invasive localization of a light-emitting conjugate in a mammal |
| 09/18/2008 | US20080226562 Stable optical imaging in vitro, in vivo; magnetic resonance imaging ; metal oxide core overcoated with polymer and chromogen |
| 09/18/2008 | US20080226561 Therapeutic use of anti-tf-antigen antibody |
| 09/18/2008 | US20080226560 Supplying cargo compound into cancer cells; cargo compound may be nucleic acids, Dna, Rna |
| 09/18/2008 | US20080226559 Benztropine Compounds and Uses Thereof |
| 09/18/2008 | US20080226556 Using macrophages;milk fat globulins; epidermal growth factor mutants |
| 09/18/2008 | US20080226555 Method for the Use of [11C] Carbon Monoxide in Labeling Synthesis of 11C-Labelled Esters and Acids by Sensitized Photo-Induced Free Radical |
| 09/18/2008 | US20080226554 Polynucleotides encoding markers |
| 09/18/2008 | US20080226553 Transfection of stem cells; cell proliferation |
| 09/18/2008 | US20080226551 Transport Molecules Using Reverse Sequence HIV-TAT Polypeptides |
| 09/18/2008 | CA2679643A1 Procaspase 8-mediated disease targeting |
| 09/17/2008 | EP1969068A2 Quinaldine based semisquaraines and squaraine dyes, process for preparation thereof and use thereof |
| 09/17/2008 | EP1968649A1 Protein nanoparticles and the use of the same |
| 09/17/2008 | EP1968648A2 Diagnostic system for the detection and diagnosis of skin cancer |
| 09/17/2008 | EP1968647A2 Diagnostic substance and method for the analysis of metabolism processes in the brain |
| 09/17/2008 | EP1968646A2 A predictive tool for hyaluronidase treatment success |
| 09/17/2008 | EP1968550A2 Nanoclusters for delivery of therapeutics |
| 09/17/2008 | EP1968442A2 In situ hyperpolarization of imaging agents |
| 09/17/2008 | EP1753467A4 Diagnostic agents for positron emission imaging using radiolabeled halogenated xanthenes and methods for positron emission imaging with radiolabeled halogenated xanthene diagnostic agents |
| 09/17/2008 | EP1713821A4 Primary central nervous system tumor specific behab isoforms |
| 09/17/2008 | CN101267844A Process for using optical agents |
| 09/17/2008 | CN100418945C Iodine Ioxilan purification method |
| 09/17/2008 | CN100418584C Method and arrangement for producing contrast agent for magnetic resonance imaging |
| 09/16/2008 | US7425318 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 09/16/2008 | US7425317 Diagnosis, therapy of tumors, cancer |
| 09/16/2008 | CA2331605C The use of a vital dye for facilitating surgical procedures for cataract extraction |
| 09/16/2008 | CA2317526C Method of magnetic resonance investigation |
| 09/16/2008 | CA2307332C Magnetic resonance imaging agents for the delivery of therapeutic agents |
| 09/16/2008 | CA2239519C Specific binding members for human carcinoembryonic antigen, materials and methods |
| 09/16/2008 | CA2195633C Blood-pool imaging compositions use and method |
| 09/16/2008 | CA2188872C Physiologically acceptable emulsions containing perfluorocarbon ether hydrides and methods of use |
| 09/12/2008 | WO2008108993A1 Ectopic, orthotopic model for revascularization and tumor assessment |
| 09/12/2008 | WO2008108944A2 Integrated photoactive small molecules and uses thereof |
| 09/12/2008 | WO2008108941A2 Integrated photoactive peptides and uses thereof |
| 09/12/2008 | WO2008108811A2 Detection of explosives using luminescence |
| 09/12/2008 | WO2008108163A1 Gadolinium compound and contrast agent for mri |
| 09/12/2008 | WO2008107422A1 Osteopontin for the prediction and treatment of cardiovascular diseases |
| 09/12/2008 | WO2008107384A1 Dehydrated granular composition and biomedical applications thereof |
| 09/12/2008 | WO2008090500A3 Method for influencing and/or detecting magnetic particles in a region of action, magnetic particles and the use of magnetic particles |
| 09/12/2008 | WO2008005533A3 Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance |
| 09/12/2008 | WO2007146595A3 Compositions and methods for diagnosis of axial pain with or without radiculopathy |
| 09/12/2008 | WO2007127801A3 Hepatitis c virus infection biomarkers |
| 09/12/2008 | WO2006076041A3 Pan-her antagonists and methods of use |
| 09/12/2008 | CA2679545A1 Osteopontin for the prediction and treatment of cardiovascular diseases |
| 09/12/2008 | CA2679539A1 Dehydrated granular composition and biomedical applications thereof |
| 09/11/2008 | US20080220077 injectable compositions comprising biocompatible, swellable, substantially hydrophilic, non-toxic and substantially spherical polymeric material carriers which are capable of efficiently delivering bioactive therapeutic factor(s) for use in embolization drug therapy |
| 09/11/2008 | US20080219933 imaging systems, designed to detect near-infrared fluorescence activation in deep tissues; molecular specificity and yield high fluorescence contrast, to allow early detection and molecular target assessment of diseased tissue, such as cancers, in vivo |
| 09/11/2008 | US20080219932 Magnetic resonance spectroscopy of breast biopsy to determine pathology, vascularization and nodal involvement |
| 09/11/2008 | US20080219931 baseline levels of amyloid deposition in the patient before treatment with the anti-amyloid agent are compared with levels of amyloid deposition in the patient following treatment; imaging the patient |
| 09/11/2008 | US20080219930 Method for the evaluation of dengue virus therapeutic agents |
| 09/11/2008 | US20080219929 Introducing into the subject a ligand capable of labelling aggregated paired helical filament (PHF) tau protein, determining the presence and/or amount of ligand bound to extracellular aggregated PHF tau in the medial temporal lobe of the brain, correlating the result of the determination |
| 09/11/2008 | US20080219928 measurement of soluble solids concentrations contained in gastric juices; monitoring feeding tolerance in a patient receiving enteral nutrition |
| 09/11/2008 | US20080219927 storage stable mixture of methyl trans-4-[3-[6-amino-9-(N-ethyl- beta -D-ribofuranosyluronamide)-9H-purin-2-yl]prop-2-ynyl]cyclohexane carboxylate, water and hydroxypropyl-beta-cyclodextrin, used for myocardial perfusion imaging |
| 09/11/2008 | US20080219926 detecting targets in humans or animal cells, comprising administering oligonucleotide-based surface-enhanced Raman spectroscopy molecular probes, including nanoparticle having a metal component and a sequence complementary to target sequences; activation with radiation and comparing signal generated |
| 09/11/2008 | US20080219925 Delta opioid receptor protein |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/10/2008 | EP1967592A1 Method of improving the efficiency of polynucleotide sequencing |
| 09/10/2008 | EP1966388A2 Targeting vector-phospholipid conjugates |
| 09/10/2008 | CN101263191A Silylamine modified nanoparticulate carriers |
| 09/10/2008 | CN101262891A Measurement of gastric acid secretion |
| 09/10/2008 | CN101262817A Multiple contrast agent injection for imaging |
| 09/10/2008 | CN101259281A Tumor targeting poly-asparagine free radical compounds and synthesizing method and use |
| 09/10/2008 | CN101259082A Root canal anti-inflammation developing agent and preparation thereof |
| 09/09/2008 | US7423143 Coupling via incubating with transferase; solid phase synthesis |
| 09/09/2008 | US7423018 Using motor proteins to identify agents for prevention and treatment of cell proliferative and autoimmune disorders; RNA interference and gene expression inhibition; ribozymes |
| 09/09/2008 | US7422869 Method for diagnosing infectious diseases |
| 09/09/2008 | US7422738 Combined cancer treatment methods using antibodies to aminophospholipids |
| 09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
| 09/09/2008 | CA2412332C Diagnosing colic type in an infant |
| 09/04/2008 | WO2008105560A1 Pharmaceutical composition comprising anti-grp78 antibody as active ingredient |